Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medipal Holdings

PUBLIC STATUS
20K-25K EMPLOYEES
7459 STOCK SYMBOL
5 INVESTMENTS
$21.30 SHARE PRICE (As of Friday Closing)
Description

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Tokyo
  • Japan
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medipal Holdings’s full profile, request a free trial.

Medipal Holdings Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.94 - $24.32 $4.74B $21.27 $1.38 526K 222M

Medipal Holdings Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 4,072,121 4,687,443 4,188,612 3,080,908
Revenue 28,712,651 28,698,883 28,383,005 28,278,690
EBITDA 686,435 697,825 712,223 613,614
Net Income 307,103 309,895 313,749 267,749
Total Assets 15,185,337 14,591,615 15,233,086 13,647,757
Total Debt 519,812 386,789 526,838 238,036
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medipal Holdings Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 07-May-2019 00000 00000 00 000.00 Drug Discovery
000000 000000 15-Mar-2017 00000 0000000 000.00 Drug Discovery 000000000 0000
0000-000000 08-Nov-2013 000000000000000000 Storage (IT)
000000000 0000000 26-Jul-2013 000000000 00000000 Holding Companies
Medie 30-Apr-2013 Merger/Acquisition Database Software
To view this company’s complete investment and acquisition history, request access »

Medipal Holdings Subsidiaries (1)

Company Name Industry Location Founded
0000-000000 Storage (IT) Tokyo, Japan 0000
To view this company’s complete subsidiary history, request access »

Medipal Holdings Executive Team (1)

Name Title Board
Seat
Contact
Info
Toshihide Yoda Senior Managing Director & Chief Director of Business Development